Concepedia

Publication | Open Access

MitraClip® Therapy in Patients with End-Stage Systolic Heart Failure

314

Citations

17

References

2011

Year

Abstract

MitraClip® therapy reduces functional MR in patients with end-stage heart failure and marked LV dysfunction and entails clinical benefit at 6 months.

References

YearCitations

Page 1